$title


Forum Archives

Here you can search the thousands of posts from our older message boards. Just click on the link for the time period you wish to search and you will be taken to the fill-out form for that volume. You can also click on the 'Return to Index' link and display all the messages in threaded form.




View Thread View Post Thread for This Board Read Prev Msg Read Next Msg

The Blood Type Diet Archives Volume 3




Re: breast cancer questions

Posted By: anonymous
Date: February-19, 1998 at 01:34:27

In Response To: breast cancer questions (Margo)

Hi there!! I'm sending you everything I have and I'm sending you all my happy thoughts! Give this to whoever is taking care of you, and teach yourself what's going on with your body! TLfDP stands for the "Townsend Letter for Doctors and Patients", and this is where most of this material is from. Take charge yourself, girl, and beat this thing! Don't you ever give up.

Melatonin after chemotherapy prolonged survival time in metastatic NSC lung cancer. It can modulate Estrogen receptor expression, inhibit breast cancer cell growth and induce tumor regression. Itís 500x more efficient at protecting cells from radiation than DMSO. TLfDP 159:98-100(96)

250 cancer patients in 4 groups . Program with CARNIVORA and basic immunomodulating compounds (vitamins, minerals, etc.) had improvement rate of 75-98% and most went into complete remission. TLfDP 172:64(97) *p.59-60 in 172(97)Lists 105 remedial substances known to aid and support cancer patients.)

Premenopausal women have an increased rate of metastases if breast cancer surgery with axillary dissection takes place during the first 14 days of the menstrual cycle (follicular phase) rather than in the last 14 days (luteal phase), probably because of higher concentrations of estrogen, reduced activity of natural killer cells and no balance of progesterone in the follicular phase. TLfDP 150:10(96)

Olive leaf extract relieved symptoms of prostate and other cancers. TLfDP 156:80(96)

Skiitake mushroom has anti-cancer properties. TLfDP 151/2:10(96)

Maitake mushrooms have extensively shown anti-tumour effects. TLfDP 151/2:84-5(96)

B-1,3 glucan from Maitake mushrooms is a macrophage activating substance from saccharomyces cerevisiae. It is also a free radical scavenger. It is orally effective, non toxic. Macrophages, when activated, can target and eliminate tumor cells (non-specifically) and remove foreign debris, stimulate additional production of immune cells in bone marrow. Injection of B-1,3 glucan into subcutaneous nodules of malignant melanoma caused resolution in just a few days, and biopsies showed no remaining melanoma, just activated macrophages. TLfDP 155:86-8(96)

Enzyme therapy: Enzymes facilitate the reaction of recognition of cancer cells by macrophages. They also activate the natural killer cells, the T-cells, induce mediators and cytokines (TNF- tumor necrosis factor), reduce the sticky fibrin layer on cancer cells which reduces chances of metastasis. TLfDP 142:83(95)

Vitamin C boosts production of antibodies and interferon, the protein that helps protect from viruses and spot tumor cells. It acts against mutagenic and carcinogenic effects of environmental pollutants by stimulating liver detoxifying enzymes and production of PGE1, a prostaglandin that assists lymphocytes. TLfDP 127/8:174(94)

High doses (200 to 600 mg daily) of germanium (organic) brings about improvement and sometimes remission of cancer. GE-132 seems to induce interferon while activating various parts of the immune system, particularly the Natural killer cells. Japanese and Swiss research have both shown that GE-132 has remarkable effects on lung cancer metastasis, making curing the primary tumor less complicated. TLfDP 141:82-90(95)

For Cancer and other degenerative diseases the Hospital Santa Monica has a 52% success rate in general. TLfDP 143:62-70(95) GREAT ARTICLE!!

Local hyperthermia treatment is being used for local breast cancer and esophagus cancers, liver cancer, bladder and skin tumors. TLfDP 144:10-11(95)

Helix pomatia agglutinin binds to breast cancers with a poor prognosis. Also prognostic for stomach, prostate and colon carcinomas. But the HPA binding glycoconjugates have not yet been identified nor have any cellular functions related to the metastatic cascade been attributed to identified HPA-binding glycoconjugates. No over-expression of any particular HPA glycoprotein is obvious in breast cancer cells. HPA can bind several glycoproteins. Glycoconj. J. 12:250-7(95)

Helix pomatia agglutinin binds to breast cancers with a poor prognosis. Also prognostic for stomach, prostate and colon carcinomas. But the HPA binding glycoconjugates have not yet been identified nor have any cellular functions related to the metastatic cascade been attributed to identified HPA-binding glycoconjugates. No over-expression of any particular HPA glycoprotein is obvious in breast cancer cells. HPA can bind several glycoproteins. Glycoconj. J. 12:250-7(95)

Catís claw, or una de gato bark, is used in Peruvian tribes to treat inflammation, rheumatism, gastric ulcers, to inhibit tumor growth, and for contraception. Also relieves side-effects of chemotherapy and boosts immune system. TLfDP 175/6:19-20(98)

IL-2 makes T-cells more cytotoxic to tumor cells. Inhalation of IL-2 has had an excellent clinical response with liver and other metastases. Inhalation of zinc oxide increases the number of IL-2 receptors that appear on T-cells. TLfDP 147:824(95)

Protease inhibitors to prevent cancer: Burger report 1970 stated that contact inhibition, which prevents cancer cells from becoming malignant is compromised by proteolytic enzymes. Injection of protease inhibitor in to animal tumors inhibited potential invasion of cancer cells and sometimes caused disappearance. TLfDP 175/6:108-10(98)

Gerson therapy of cancers: 17 patients with stage 3 melanoma, 82% alive at 5 years compared to 39% of103 patients on normal therapy. Stage 4A melanoma: 18 patients: 39% alive at 5 years compared to 6% of 194 on standard treatment. TLfDP 153:33(96)

8 end-stage cancer patients in 11 week trial given a mixture of 91% shark cartilege protein and 7% moisture, 7 patients responded and 5 were tumor free after 11 weeks. 2 had 80% tumor reduction and one died. May be anti-mitotic and is anti-angiogenic. 29 terminal patients at 38 months taking 1g/kg daily, 48% are now cancer free. Only 31% died of cancer. TLfDP 153:40(96)

ABL lectin from the edible mushroom Agaricus bisporus causes human colorectal and breast carcinoma cells to stop proliferating (dose dependant). No toxic effects. (Lugang et.al. 1993)

PNA binding to breast cancer cells inhibited proliferation in culture. Not all breast cancer cell lines can bind PNA. Retinoic acid, which reduces PNA binding, did not reduce PNAís effect on proliferation. The combination lead to an additive growth-inhibitory action. In one case PNA binding made a cell line more susceptible to interferon y. (Marth and Daxinbichler 1988)

HPA binds breast cancer tissue when it is near metastatic stage. Since it is an agglutinin it probably causes these cells to clump up an maybe be more easily targeted by the immune system. (Fenlon 1987)

HPA binds to Breast cancer cells. (Brooks and Leathem 1991)

ABL lectin can bind sialyated Gal-1,3-Nacetylgalactosamine. ABL inhibits incorporation of [3H]thymidine into DNA of HT-29 colon cancer cells by 87%m /caca-2 Colon cancer cells by 16%, MCF-7 breast cancer cells by 50% and Rama-27 rat mammary fibroblasts by 55% (this means that it will stop the cancer cells from dividing into new ones because they won't be able to get the materials they need to divide and re-divide) (Yu et.al. 1993)

In human breast cancer (MDA-MB-435 cell line) synthetic glycosamines blocked PNA lectins interaction with B-gal. Synthetics used were Fru-D-Leu and Lac-L-Leu.. Fru-L-Leu had anti-metastatic action in vitro but not in vivo. (Glinsky et.al. 1996)

Peanut agglutinin strongly binds to normal mammary epithelium and this binding strength is progressively lost with increasing malignancy (50 times less strong when malignant) (Rak et.al. 1992)

ML-1 is galactose specific, ML-2 is Galactose and N-acetyl-D-galactosamine specific and ML-3 is N-acetyl galactosamine specific. Several studies have shown that immunological parameters of cancer patients can be changed favorably by the application of mistletoe extracts containing MLís. The dose of ML-1required to be toxic to breast cancer cells (10 ng/ml) is 40X higher than he dose needed to activate lymphocytes in culture. Immunostimulatory effects could be observed after giving patients suffering from advanced breast cancer 1 ng of ML-1 per kg body weight for 4 weeks. ML-1 and 3 have almost identical binding characteristics, and ML-2 is different. (Schumacher et.al. 1995)

In metastatic breast cancer there are a number of cell membrane constituents known to contain N-acetylgalactosamine residues that may be of structural importance like epidermal growth factor and the transferrin receptor. EGF expression increases in bad prognosis breast cancers and may act as a cell-adhesion molecule, therefore it may be important in metastasis. Iron is essential for metabolism of breast cancer cells. (Mitchell et.al.1995)

Expression of PNA receptor binding sites in ductal breast cancer cells is associated with the expression of estrogen receptors in these cells. It measures the functional differentiation of tumor cells via differential expression of glycoproteins. (Mustak et.al. 1996)




Messages in This Thread

View Thread View Post Thread for This Board Read Prev Msg Read Next Msg

Password:



GenoType Diet Website   ♦   Dr. D'Adamo's Clinic   ♦   Institute for Human Individuality   ♦   Newsletter   ♦   Para Su Tipo de Sangre   ♦   Professionals   ♦  The Individualist

The statements made on our websites have not been evaluated by the FDA (U.S. Food & Drug Administration).
Our products and services are not intended to diagnose, cure or prevent any disease. If a condition persists, please contact your physician.
Copyright © 2010, North American Pharmacal, Inc. All Rights Reserved